Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients

• Bridget Draper,
• Win Lei Yee,
• Alisa Pedrana,
• Khin Pyone Kyi,
• Huma Qureshi,
• Hla Htay,
• Win Naing,
• Alexander J Thompson,
• Margaret Hellard,
• Jessica Howell

Affiliations

Bridget Draper

Disease Elimination Program, Burnet Institute Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University Melbourne, Australia; Corresponding author: Bridget Draper, 85 Commercial Road, Melbourne, 3004 Victoria, Australia, +61 3 8506 2395.

Win Lei Yee

Burnet Institute Yangon, Myanmar

Alisa Pedrana

Disease Elimination Program, Burnet Institute Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University Melbourne, Australia; Health Services Research and Implementation, Monash Partners, Melbourne, Australia

Khin Pyone Kyi

Myanmar Liver Foundation

Huma Qureshi

Gastroenterologist, Doctors Plaza, Clifton, Karachi, Pakistan

Hla Htay

Burnet Institute Yangon, Myanmar

Win Naing

Myanmar Liver Foundation; Yangon Specialty Hospital, Myanmar

Alexander J Thompson

St Vincent's Hospital Melbourne, Australia; Department of Medicine, University of Melbourne, Australia

Margaret Hellard

Disease Elimination Program, Burnet Institute Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University Melbourne, Australia; Hepatitis Services, Department of Infectious Diseases Alfred Hospital Melbourne Australia; Doherty Institute, Melbourne, Australia; School of Population and Global Health, University of Melbourne, Australia

Jessica Howell

Disease Elimination Program, Burnet Institute Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University Melbourne, Australia; St Vincent's Hospital Melbourne, Australia; Department of Medicine, University of Melbourne, Australia